Posted on

ObamaCare patients with serious pre-existing diseases could face expensive drug costs

1379441947-obamacare3-300x277

ObamaCare patients with serious pre-existing diseases could face expensive drug costs
By Jim Angle
Published February 16, 2014
FoxNews.com

People with serious pre-existing diseases, precisely those the president aimed to help with ObamaCare, could find themselves paying for expensive drug treatments with no help from the health care exchanges.

Those with expensive diseases such as lupus or multiple sclerosis face something called a “closed drug formulary.”

Dr. Scott Gottlieb of the American Enterprise Institute explains,”if the medicine that you need isn’t on that list, it’s not covered at all. You have to pay completely out of pocket to get that medicine, and the money you spend doesn’t count against your deductible, and it doesn’t count against your out of pocket limits, so you’re basically on your own.”

The plan had claimed it would rescue those with serious pre-existing conditions.

“So it could be that a MS patient could be expected to pay $62,000 just for one medication,” says Dr. Daniel Kantor, who treats MS patients and others with neurological conditions near Jacksonville, Florida. “That’s a possiblity under the new ObamaCare going on right now.”

In fact, one conservative group, Americans for Prosperity, is running an ad on exactly this subject, featuring a woman with lupus, an auto-immune disease.

She starts by saying, “I voted for Barack Obama for president. I thought ObamaCare was going to be a good thing.”

But Emilie Lamb says she later got a letter saying her insurance was canceled because of ObamaCare, pushing her premiums from $52 to $373 a month.

https://www.foxnews.com/politics/2014/02/16/obamacare-patients-with-serious-pre-existing-diseases-could-face-expensive-drug/?intcmp=latestnews

Posted on

Obamacare Enrollment Rate Slows Markedly In January

1379441947-obamacare3-300x277

Obamacare Enrollment Rate Slows Markedly In January
7:01 AM, Feb 13, 2014 • By JAY COST

On Wednesday, the Department of Health and Human Services announced that enrollment in the Obamacare private exchanges increased by 1,146,071 in January. In December, HHS reported 1,788,000 enrollees in the month of December. That suggests a drop-off of approximately 500,000, or 29 percent. (See the chart on page 5 here for a graphical representation).

Yet this underestimates the true extent of enrollment dropoffs. The HHS reporting period for December was four weeks, beginning on 12/1 and ending on 12/28. The reporting period for January was five weeks, beginning on 12/29 and ending on 2/1. This suggests that in December, enrollments averaged 447,000 per week, compared to 229,000 in January, or a 49 percent drop-off in new enrollees.

https://www.weeklystandard.com/blogs/obamacare-enrollment-rate-slows-markedly-january_781553.html

Posted on

Shortages of Critical Drugs Continue to Vex Doctors, Study Finds

1379441947-obamacare

Shortages of Critical Drugs Continue to Vex Doctors, Study Finds

By SABRINA TAVERNISEFEB. 10, 2014

Despite efforts by the Obama administration to ease shortages of critical drugs, shortfalls have persisted, forcing doctors to resort to rationing in some cases or to scramble for alternatives, a government watchdog agency said on Monday.

In recent years, drug shortages have become an all but permanent part of the American medical landscape. The most common shortages are for generic versions of sterile injectable drugs, partly because factories that make them are aging and prone to quality problems, causing temporary closings of production lines or even entire factories. The number of annual shortages — both new and continuing ones — nearly tripled from 2007 to 2012.

The analysis by the United States Government Accountability Office, released Monday, was required by a 2012 law that gave the Food and Drug Administration more power to manage shortages. The watchdog agency was charged with evaluating whether the F.D.A. had improved its response to the problem, among other things.

The accountability office concluded that the F.D.A. was preventing many more shortages now than in the past — 154 potential shortages in 2012 compared with just 35 in 2010 — but that the number of shortages has continued to grow.

https://www.nytimes.com/2014/02/11/health/shortages-of-critical-drugs-continue-to-vex-doctors-study-finds.html?_r=0

Posted on

White House delays health insurance mandate for medium-sized employers until 2016

1379441947-obamacare
White House delays health insurance mandate for medium-sized employers until 2016

By Juliet Eilperin and Amy Goldstein, E-mail the writers

The Obama administration announced Monday it would give medium-sized employers an extra year, until 2016, before they must offer health insurance to their full-time workers.

Firms with at least 100 employees will have to start offering this coverage in 2015.

https://www.washingtonpost.com/national/health-science/white-house-delays-health-insurance-mandate-for-medium-sized-employers-until-2016/2014/02/10/ade6b344-9279-11e3-84e1-27626c5ef5fb_story.html

Posted on

CBO nearly triples estimate of working hours lost by 2021 due to Affordable Care Act

1379441947-obamacare

CBO nearly triples estimate of working hours lost by 2021 due to Affordable Care Act

No compelling evidence Obamacare increased part-time work: CBO

Tuesday, 4 Feb 2014 | 11:00 AM ET

A historically high number of people will be locked out of the workforce by 2021, according to a report by the Congressional Budget Office released Tuesday.

President Barack Obama’s signature health-care law will contribute to this phenomenon, the CBO said, citing new estimates that the Affordable Care Act will cause a larger-than-expected reduction in working hours—eliminating the equivalent of about 2.3 million workers in 2021.

In 2011, the CBO estimated the law would cause a reduction of about 800,000 full-time equivalent workers.

“CBO estimates that the ACA will reduce the total number of hours worked, on net, by about 1.5 to 2 percent during the period from 2017 to 2024, almost entirely because workers will choose to supply less labor—given the new taxes and other incentives they will face and the financial benefits some will receive,” said the report.

“The reduction in CBO’s projections of hours worked represents a decline in the number of full-time-equivalent workers of about 2.0 million in 2017, rising to about 2.5 million in 2024,” it added.

https://www.cnbc.com/id/101352868